Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × secukinumab × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 540 Specimen Handling 508 Magnetic Resonance Spectroscopy 437 Carboplatin 352 Cyclophosphamide 333 Biopsy 305 Cisplatin 295 Paclitaxel 265 Nivolumab 254 Gemcitabine 228 Radiotherapy 222 Bevacizumab 193 Dexamethasone 190 fludarabine 183 venetoclax 178 Oxaliplatin 159 Docetaxel 156 Fluorouracil 154 atezolizumab 153 durvalumab 152 Rituximab 148 Capecitabine 143 Pemetrexed 142 Doxorubicin 134 Radiation 130 Lenalidomide 128 Prednisone 124 Standard of Care 122 Radiosurgery 118 Drug Therapy 118

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07237594 2026-03-11

REPLAY

Duke University

Phase 1 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡